News About: Pharm. Industry
New Accu-Chek Active goes on sale
Roche Diagnostics Korea held its recent launching symposium of an updated version of Accu-Chek Active (model No. GC) at Plaza Hotel in Seoul.
The new Accu-Chek Active is a compact, convenient and precise device whi...
Sanofi-Aventis to invest 70 billion won in Korea
Sanofi-Aventis, the world's the world's fourth-largest pharmaceutical firm, will invest 70 billion won ($55.4 million) for joint research and development (R&D) of new drugs and medical technology by 2013, it was annou...
Sanofi-Aventis to strengthen joint R&D with Korean partners
Sanofi-Aventis, a French-based pharmaceutical company, plans to strengthen research and development (R&D) capability in Korea in cooperation with local research institutes to step up studies in the related therapeutic...
Daewoong’s co-marketing strategies gaining momentum
Daewoong is re-operating its co-marketing engines through a number of strategic alliances with multinational companies, such as Janssen Korea (Utracet), MSD Korea (Januvia, Fosamax), Daiichi Sankyo Korea (Almetec).
...
Dongwha to invest 35 billion won for central research center
Dongwha Pharm will invest about 35 billion won to build a central research center at Kiheung valley, Yongin of Kyunggi Province, a company spokesman said.
On June 15, a groundbreaking ceremony was held at such vall...
Government to get tougher on illegal rebate
The government will step up its fight against chronic illegal rebate practices whereby doctors and pharmacists receive money from drug makers in return for prescribing or recommending their products, according to the ...
Wyeth Korea releases first-in-class antibiotic
Wyeth Korea, a Korean unit of Wyeth, has launched Tygacil (tigecycline) with an expanded broad spectrum of in vitro activity against many gram positives, gram negatives, anaerobes, methicillin-resistant and -susceptib...
Alliance with Daewoong positive for Janssen Korea
Analysts say the strategic alliance between Janssen Korea and Daewoong Pharm is likely to help boost the former’s Ultracet (acetaminophen 325 mg + tramadol 37.5 mg) in sales.
“The partnership is positive as it give...
Ilyang, Chungnam Univ. signs MOU over new influenza vaccine
Ilyang Pharm and Chungnam National University signed a technical transfer agreement on June 15 to provide data to let Ilyang make new influenza vaccines
The scientists at Chungnam National University said on May 18...
LG completes phase 3 trial for sustained release recombinant human growth hormone
LG Life Sciences Ltd., a Korean pharmaceutical manufacturer, said on June 11 that it has successfully completed phase 3, placebo-controlled six month efficacy and safety data in adults with growth hormone deficiency (...
